Astera Labs, Inc. (NASDAQ:ALAB) Receives $159.83 Consensus PT from Analysts

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have earned an average rating of “Moderate Buy” from the twenty-three ratings firms that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $162.0556.

A number of equities research analysts have issued reports on the stock. Citigroup upped their price target on shares of Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday, September 17th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, September 2nd. Evercore ISI increased their target price on shares of Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, August 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Finally, Northland Capmk cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 22nd.

Insider Transactions at Astera Labs

In related news, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.02, for a total value of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. This represents a 4.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $173.42, for a total transaction of $4,335,500.00. Following the completion of the transaction, the director directly owned 99,154 shares of the company’s stock, valued at $17,195,286.68. This trade represents a 20.14% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,092,997 shares of company stock valued at $192,231,120. Corporate insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Great Valley Advisor Group Inc. grew its stake in shares of Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after purchasing an additional 90 shares during the last quarter. Straight Path Wealth Management grew its stake in shares of Astera Labs by 1.5% during the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after purchasing an additional 100 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of Astera Labs by 12.4% during the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after purchasing an additional 108 shares during the last quarter. Advisors Asset Management Inc. grew its stake in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares during the last quarter. Finally, Berbice Capital Management LLC grew its stake in shares of Astera Labs by 14.3% during the second quarter. Berbice Capital Management LLC now owns 1,600 shares of the company’s stock valued at $145,000 after purchasing an additional 200 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

ALAB stock opened at $159.80 on Friday. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90. The company has a 50-day moving average of $199.68 and a two-hundred day moving average of $128.80. The stock has a market capitalization of $26.56 billion, a price-to-earnings ratio of 285.36, a price-to-earnings-growth ratio of 3.98 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million during the quarter, compared to analysts’ expectations of $172.46 million. During the same period in the prior year, the company earned $0.13 earnings per share. The business’s quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts expect that Astera Labs will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.